StockData
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Cronos Group Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.25+0.04 (+1.25%)

Close on Oct 19, 2026

Market cap
$1.22B
P/E (TTM)
16.3
Dividend yield
–

Cronos Group Inc. revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017% of revenueYoY
Rest Of World Segment–––$86.75M$64.56M$37.22M$20.39M$12.12M$3.15M––
United States Segment–––$5.16M$9.87M$9.50M$3.36M$0$0––

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017% of revenueYoY
Cannabis flower$108.48M$87.91M$62.07M$63.59M$55.19M$27.93M$15.02M$9.21M$2.88M74.0%+23.4%
Cannabis extracts$37.70M$29.17M$24.57M$22.52M$8.81M$18.25M$8.70M$2.73M$113.00K25.7%+29.3%
Other$411.00K$535.00K$602.00K$634.00K$560.00K$533.00K$28.00K$179.00K$150.00K0.3%-23.2%

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017% of revenueYoY
Canada$90.33M$82.44M$64.70M$56.23M$50.29M$34.54M$20.20M$11.20M$2.69M61.6%+9.6%
Israel$41.80M$28.37M$21.13M$30.52M$13.38M$2.54M–––28.5%+47.3%
Other countries$14.46M$6.81M$1.41M$0$891.00K$147.00K$184.00K$926.00K$461.00K9.9%+112.3%
United States–––$5.16M$9.87M$9.50M$3.36M$0$0––

From the segment and revenue-disaggregation notes of Cronos's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.